Integer Holdings Corp
ITGR106.520USD
-1.990-1.83%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
3.73BMarket Cap
48.53P/E TTM
More Details of Integer Holdings Corp Company
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
Company Info
Ticker SymbolITGR
Company nameInteger Holdings Corp
IPO dateSep 29, 2000
Founded at1997
CEOMr. Payman Khales
Number of employees11000
Security typeOrdinary Share
Fiscal year-endSep 29
Address5830 Granite Parkway., Suite 1150
CityPLANO
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code75024
Phone12146185243
Websitehttps://www.integer.net/home/default.aspx
Ticker SymbolITGR
IPO dateSep 29, 2000
Founded at1997
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Pamela G. Bailey
Ms. Pamela G. Bailey
Independent Chairman of the Board
Independent Chairman of the Board
53.17K
--
Mr. Joseph W. (Joe) Dziedzic
Mr. Joseph W. (Joe) Dziedzic
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
45.81K
+99.16%
Mr. Filippo Passerini
Mr. Filippo Passerini
Independent Director
Independent Director
29.15K
+5.48%
Mr. Kirk K. Thor
Mr. Kirk K. Thor
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
26.69K
+26.53%
Mr. Payman Khales
Mr. Payman Khales
President, Chief Executive Officer
President, Chief Executive Officer
19.74K
--
Ms. Sheila Antrum
Ms. Sheila Antrum
Independent Director
Independent Director
10.10K
+17.63%
Ms. Cheryl C. Capps
Ms. Cheryl C. Capps
Independent Director
Independent Director
10.10K
+17.63%
Mr. Andrew Senn
Mr. Andrew Senn
Senior Vice President - Strategy, Business Development and Investor Relations
Senior Vice President - Strategy, Business Development and Investor Relations
9.41K
+41.84%
Ms. Margaret Carthy
Ms. Margaret Carthy
Executive Vice President - Quality and Regulatory Affairs
Executive Vice President - Quality and Regulatory Affairs
7.69K
+33.69%
Mr. James F. (Jim) Hinrichs
Mr. James F. (Jim) Hinrichs
Independent Director
Independent Director
7.42K
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Pamela G. Bailey
Ms. Pamela G. Bailey
Independent Chairman of the Board
Independent Chairman of the Board
53.17K
--
Mr. Joseph W. (Joe) Dziedzic
Mr. Joseph W. (Joe) Dziedzic
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
45.81K
+99.16%
Mr. Filippo Passerini
Mr. Filippo Passerini
Independent Director
Independent Director
29.15K
+5.48%
Mr. Kirk K. Thor
Mr. Kirk K. Thor
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
26.69K
+26.53%
Mr. Payman Khales
Mr. Payman Khales
President, Chief Executive Officer
President, Chief Executive Officer
19.74K
--
Ms. Sheila Antrum
Ms. Sheila Antrum
Independent Director
Independent Director
10.10K
+17.63%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Cardio & Vascular
258.87M
59.19%
Cardiac Rhythm Management & Neuromodulation
160.34M
36.66%
Advanced Surgical, Orthopedics & Portable Medical
18.18M
4.16%
By RegionUSD
Name
Revenue
Proportion
United States
227.44M
52.00%
Rest of the world
209.95M
48.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Cardio & Vascular
258.87M
59.19%
Cardiac Rhythm Management & Neuromodulation
160.34M
36.66%
Advanced Surgical, Orthopedics & Portable Medical
18.18M
4.16%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.76%
The Vanguard Group, Inc.
10.75%
Dimensional Fund Advisors, L.P.
4.39%
Capital Research Global Investors
3.97%
State Street Global Advisors (US)
3.75%
Other
63.38%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.76%
The Vanguard Group, Inc.
10.75%
Dimensional Fund Advisors, L.P.
4.39%
Capital Research Global Investors
3.97%
State Street Global Advisors (US)
3.75%
Other
63.38%
Shareholder Types
Shareholders
Proportion
Investment Advisor
58.25%
Investment Advisor/Hedge Fund
46.88%
Hedge Fund
2.81%
Research Firm
2.57%
Pension Fund
2.56%
Private Equity
1.89%
Individual Investor
0.96%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.11%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
683
40.92M
116.78%
-1.48M
2025Q1
700
41.74M
119.68%
-1.08M
2024Q4
670
41.42M
123.22%
-994.58K
2024Q3
653
40.89M
121.94%
-427.20K
2024Q2
625
40.11M
119.73%
+366.52K
2024Q1
603
38.21M
114.03%
-340.06K
2023Q4
562
37.63M
112.90%
-432.57K
2023Q3
551
37.37M
112.20%
-2.46M
2023Q2
536
37.65M
113.15%
-2.07M
2023Q1
527
37.57M
112.97%
+850.44K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
4.82M
13.81%
-148.18K
-2.98%
Mar 31, 2025
The Vanguard Group, Inc.
3.77M
10.8%
-60.34K
-1.58%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.54M
4.41%
-161.92K
-9.52%
Mar 31, 2025
Capital Research Global Investors
1.39M
3.99%
-18.24K
-1.29%
Mar 31, 2025
State Street Global Advisors (US)
1.31M
3.76%
-41.54K
-3.07%
Mar 31, 2025
Invesco Advisers, Inc.
1.30M
3.72%
+41.09K
+3.27%
Mar 31, 2025
Viking Global Investors LP
1.18M
3.37%
+21.56K
+1.87%
Mar 31, 2025
EARNEST Partners, LLC
1.14M
3.27%
-21.57K
-1.85%
Mar 31, 2025
Columbia Threadneedle Investments (UK)
836.99K
2.4%
+27.52K
+3.40%
Mar 31, 2025
Fuller & Thaler Asset Management Inc.
794.27K
2.28%
-182.90K
-18.72%
Mar 31, 2025
View more
Related ETFs
Updated: 3 hours ago
Updated: 3 hours ago
Name
Proportion
Invesco S&P SmallCap Health Care ETF
3.07%
AAM Sawgrass US Small Cap Quality Growth ETF
2.29%
SPDR S&P Health Care Equipment ETF
1.87%
Invesco S&P SmallCap Momentum ETF
0.83%
Invesco S&P SmallCap Low Volatility ETF
0.78%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.63%
SPDR S&P 600 Small Cap Growth ETF
0.62%
Texas Capital Texas Small Cap Equity Index ETF
0.6%
iShares S&P Small-Cap 600 Growth ETF
0.59%
Invesco S&P SmallCap 600 Pure Growth ETF
0.52%
View more
Invesco S&P SmallCap Health Care ETF
Proportion3.07%
AAM Sawgrass US Small Cap Quality Growth ETF
Proportion2.29%
SPDR S&P Health Care Equipment ETF
Proportion1.87%
Invesco S&P SmallCap Momentum ETF
Proportion0.83%
Invesco S&P SmallCap Low Volatility ETF
Proportion0.78%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.63%
SPDR S&P 600 Small Cap Growth ETF
Proportion0.62%
Texas Capital Texas Small Cap Equity Index ETF
Proportion0.6%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.59%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.52%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
